Company Filing History:
Years Active: 1990-1992
Title: Innovations by Henry V Roohk in Extracorporeal Blood Treatment
Introduction
Henry V Roohk is an accomplished inventor based in Westminster, CA (US). He has made significant contributions to the field of medical technology, particularly in the treatment of blood-borne infections. With a total of 2 patents, Roohk's work focuses on innovative methods for extracorporeal blood treatment.
Latest Patents
Roohk's latest patents include a "Method and apparatus for extracorporeal blood treatment" and a "Method for extracorporeal blood shear treatment." Both patents disclose a multimodal approach to treating infections, such as those caused by the Human Immunodeficiency Virus (HIV). The methods involve hyperthermic, mechanical shear inducing, and irradiation treatment modalities. These treatment modalities can be performed separately, in any order, or simultaneously. The irradiation treatment includes subjecting blood to ultraviolet, x-ray, or laser radiation. Prior to blood withdrawal, a chemical agent like heparin may be administered to facilitate lymphocyte migration from the lymphatic system into the circulatory system. After extracting the desired volume of blood, volume extenders can be mixed with the blood to adjust the extracorporeal blood volume as needed. Once the extracorporeal treatments are completed, the treated blood is returned to the patient.
Career Highlights
Henry V Roohk is associated with American Immuno Tech, LLC, where he continues to develop and refine his innovative medical technologies. His work has the potential to significantly impact the treatment of blood-borne infections, providing new hope for patients affected by such conditions.
Collaborations
Roohk collaborates with notable professionals in his field, including Alan A Davidner and Max D Lechtman. Their combined expertise contributes to the advancement of medical technologies and the development of effective treatment methods.
Conclusion
Henry V Roohk's contributions to the field of extracorporeal blood treatment demonstrate his commitment to innovation in medical technology. His patents reflect a deep understanding of complex medical challenges and a dedication to improving patient outcomes.